Regina Danielson

Company: AstraZeneca

Job title: Senior Vice President & Head of Research & Early Development

Seminars:

Myeloperoxidase – A Key Target Involved in the Progression of HFpEF 9:00 am

Learn how disease drivers in HFpEF are different to HFrEF Understand how MPO is linked to HFpEF severity, and involved in fibrosis, inflammation, and microvascular dysfunction Explore how inhibiting MPO has beneficial effects in patients with HFpEFRead more

day: Day One